About Quiver Bioscience
Quiver Bioscience is a company based in Cambridge (United States) founded in 2013 by Paul Roma, Graham Dempsey, and David Margulies was acquired by Exponential Capital in July 2023. Quiver Bioscience offers products and services including Drug Discovery Platform, Cellular Models, and AI Analytics. Quiver Bioscience operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Cambridge, United States
- Founders Paul Roma, Graham Dempsey, David Margulies
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
NIH
& 2 more
-
Employee Count
Not available
-
Acquired by
Exponential Capital
(Jul 06, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quiver Bioscience
Quiver Bioscience offers a comprehensive portfolio of products and services, including Drug Discovery Platform, Cellular Models, and AI Analytics.
Platform for identifying therapeutic targets in neurological diseases.
Tools for producing neurons to analyze brain cell functions.
System to extract insights from cellular data for drug optimization.
Funding Insights of Quiver Bioscience
Investors in Quiver Bioscience
Quiver Bioscience has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Exponential Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Exponential Capital is engaged in healthcare technology venture investments.
|
Locked | Locked | Locked |
Investor details for Quiver Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quiver Bioscience
Investment portfolio details for Quiver Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quiver Bioscience
Detailed financials for Quiver Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quiver Bioscience Comparisons
Peer comparison for Quiver Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quiver Bioscience
Quiver Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| Locked | Locked | Locked |
Small molecule drugs for rare diseases are developed.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
Detailed competitors of Quiver Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quiver Bioscience
Complete news archive for Quiver Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quiver Bioscience
Quiver Bioscience was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Quiver Bioscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Quiver Bioscience was founded in 2013 and is based in Cambridge, United States. Medicines for neurological disorders are developed through a proprietary platform that integrates advanced human cellular models, measurement engineering, artificial intelligence, and machine learning. The lead candidate, UBE3A, targets seizure and neurodevelopment disorders. Operations focus on drug discovery in the biotechnology sector.
Quiver Bioscience's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
Quiver Bioscience offers Drug Discovery Platform, Cellular Models, and AI Analytics.
Quiver Bioscience has 3 investors. Key investors include NIH, HHS, and Exponential Capital.